WITHDRAWN: MiR-760 inhibits the progression of non-small cell lung cancer through blocking ROS1 /Ras/Raf/MEK/ERK pathway

Wei Wang,Bin He

DOI: https://doi.org/10.1042/bsr20182483

2020-01-01

Bioscience Reports

Abstract:The Accepted Manuscript version of this article (published on 29 April 2020) was withdrawn on 8 June 2020 due to concerns over authorship and data validity.

What problem does this paper attempt to address?

MiR-30 Suppresses Lung Cancer Cell 95D Epithelial Mesenchymal Transition and Invasion Through Targeted Regulating Snail.

M-J Fan,Y-H Zhong,W Shen,K-F Yuan,G-H Zhao,Y Zhang,S-K Wang

DOI: https://doi.org/10.26355/eurrev_202009_22986

2020-01-01

European review for medical and pharmacological sciences

Abstract:Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "MiR-30 suppresses lung cancer cell 95D epithelial mesenchymal transition and invasion through targeted regulating Snail, by M.-J. Fan, Y.-H. Zhong, W. Shen, K.-F. Yuan, G.-H. Zhao, Y. Zhang, S.-K. Wang, published in Eur Rev Med Pharmacol Sci 2017; 21 (11): 2642-2649-PMID: 28678320" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/12883.
WITHDRAWN: Mir-504 Affects the Radio-Resistance in Nasopharyngeal Carcinoma by Down-Regulating the Expression of Nuclear Respiratory Factor 1

Luqing Zhao,Zheyu Hu,Min Tang,Bin Yan,Jingchen Lu,Lanbo Xiao,Zhijie Xu,Ya Cao

DOI: https://doi.org/10.1016/j.biocel.2013.09.012

IF: 5.652

2013-01-01

The International Journal of Biochemistry & Cell Biology

Abstract:This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.
[Retracted] MicroRNA‑874 Inhibits Growth, Induces Apoptosis and Reverses Chemoresistance in Colorectal Cancer by Targeting X‑linked Inhibitor of Apoptosis Protein

Jinfeng Han,Zhongmin Liu,Nanya Wang,Weiyun Pan

DOI: https://doi.org/10.3892/or.2022.8280

2022-01-01

Oncology Reports

Abstract:Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that certain of the western blotting data shown in Fig. 5D were strikingly similar to data appearing in different form in other articles by different authors. Owing to the fact that the contentious data in the above article had already been published elsewhere prior to its submission to Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they agreed with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused. [the original article was published on Oncology Reports 36: 542‑550, 2016; DOI: 10.3892/or.2016.4810].
[Retracted] miR‐17‐5p promotes the growth of osteosarcoma in a BRCC2‐dependent mechanism

Wei Wang,Liang Zhang,Ke Zheng,Xiaojing Zhang

DOI: https://doi.org/10.3892/or.2024.8710

2024-01-31

Oncology Reports

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the western blotting data shown in Fig. 7 on p. 1480 were strikingly similar to data that had already been published in another article written by different authors at different research institutes, which has subsequently been retracted [Fan C, Wang Y, Liu Z, Sun Y, Wang X, Wei G and Wei J: Metformin exerts anticancer effects through the inhibition of the Sonic hedgehog signaling pathway in breast cancer. Int J Mol Med 36: 204‐214, 2015]. Owing to the fact that the contentious data in the above article were already under consideration for publication prior to its submission to Oncology Reports , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 35: 1473‐1482, 2016; DOI: 10.3892/or.2016.4542]

oncology
[Retracted] MicroRNA‐520a attenuates proliferation of Raji cells through inhibition of AKT1/NF‐κB and PERK/eIF2α signaling pathway

Xiaojuan Wang,Pei Wang,Yan Zhu,Zhi Zhang,Jinqian Zhang,Hongwei Wang

DOI: https://doi.org/10.3892/or.2024.8706

2024-01-23

Oncology Reports

Abstract:Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that a pair of the lanes featured in the western blot gel for Fig. 3B on p. 1705 were strikingly similar, suggesting that the same data may have been imported into the figure to represent data that were intended to show the results from differently performed experiments. In addition, the western data shown in Fig. 6 on p. 1706 for the GRP78 and the p‐PERK proteins also appeared to be strikingly similar, such that the same data may have also been inserted into this figure to show the results from different experiments. Finally, certain of the data in this paper were shown to have appeared in a previous publication that featured some of the same authors, albeit in different form [Zhang L, Huang D, Wang Q, Shen D, Wang Y, Chen B, Zhang J and Gai L: MiR‐132 inhibits expression of SIRT1 and induces pro‐inflammatory processes of vascular endothelial inflammation through blockade of the SREBP‐1c metabolic pathway. Cardiovasc Drugs Ther 8: 303‐311, 2014]. Owing to the fact that some of the contentious data in the above article had already been published elsewhere prior to its submission to Oncology Reports , and because of an overall lack of confidence in the presented data, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 36: 1702‐1708, 2016; DOI: 10.3892/or.2016.4975]

oncology
Withdrawal: Down‐regulation of Circrna_0000143 Regulates Mir‐142‐3p/grα Axis to Facilitate the Progression of T‐ALL

Juan Tong,Huilan Liu,Wen Yao,Lei Zhang,Kaidi Song,Guangyu Sun,Zimin Sun

DOI: https://doi.org/10.1111/cas.15082

IF: 5.7

2021-01-01

Cancer Science

Abstract:The above article from Cancer Science, published online on 26 July 2021 in Wiley Online Library (http://wileyonlinelibrary.com) has been withdrawn by agreement among the Journal Editor-in-Chief Masanori Hatakeyama, the Japanese Cancer Association, and John Wiley and Sons Australia, Ltd. The withdrawal has been agreed because the authors have not responded to repeated attempts to contact them to correct and approve the article proofs for publication of the version of record.
[Retracted] MicroRNA‐219 is downregulated in non‐small cell lung cancer and inhibits cell growth and metastasis by targeting HMGA2

Xiaoping Sun,Min Xu,Haiyan Liu,Kunxiu Ming

DOI: https://doi.org/10.3892/mmr.2024.13237

IF: 3.423

2024-05-10

Molecular Medicine Reports

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the Transwell migration and invasion assay data shown in Figs. 2C and 4C were strikingly similar to data that had already been published in different form in another article written by different authors at a different research institute [Yang S, Zhang Y, Zhao X, Wang J and Shang J: microRNA‐361 targets Wilms' tumor 1 to inhibit the growth, migration and invasion of non‐small‐cell lung cancer cells. Mol Med Rep 14: 5415‐5421, 2016]. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Molecular Medicine Reports , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 16: 3557‐3564, 2017; DOI: 10.3892/mmr.2017.7000]

oncology,medicine, research & experimental
MicroRNA-664 Targets Paired Box Protein 6 to Inhibit the Oncogenicity of Pancreatic Ductal Adenocarcinoma.

Qi Wang,Jiaqi Wang,Songtao Niu,Songsong Wang,Yibin Liu,Xiaoya Wang

DOI: https://doi.org/10.3892/ijo.2019.4759

2019-01-01

International Journal of Oncology

Abstract:Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that several of the panels showing flow cytometric assay data in Figs. 2D, 5D and 6E, western blotting data featured in Fig. 7, and certain of the cell migration assay data panels included in Fig. 5E and F and Fig. 6G were strikingly similar to data appearing in different form in other articles by different authors. Owing to the fact that the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to International Journal of Oncology, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [International Journal of Oncology 54: 1884‑1896, 2019; DOI: 10.3892/ijo.2019.4759].
Retraction Notice to “corrigendum to ‘Microrna-134 Prevents the Progression of Esophageal Squamous Cell Carcinoma Via the PLXNA1-mediated MAPK Signalling Pathway’ [ebiomedicine 46 (2019) 66–78]” [ebiomedicine 55 (2020) 102772]

Wei -Wei Wang,Zhi-Hua Zhao,Li Wang,Pan Li,Kui-Sheng Chen,Jian-Ying Zhang,Wen-Cai Li,Guo-Zhong Jiang,Xiang -Nan Li

DOI: https://doi.org/10.1016/j.ebiom.2024.105106

IF: 11.205

2024-01-01

EBioMedicine

Abstract:This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/policies/article-withdrawal). This article has been retracted at the request of the editors. Following a request from the authors, the editors of eBioMedicine are retracting the above article. A Corrigendum for the paper was originally issued on May 2020. However, the editors became aware of several potential figure panel duplications between Figure 7c of the paper and Figure 7a of an unrelated manuscript published by Zheng and colleagues, entitled "MicroRNA-433 inhibits oral squamous cell carcinoma cells by targeting FAK" Oncotarget. 2017; 8:100227–100241. https://doi.org/10.18632/oncotarget.22151. Given the nature and extent of the image duplications found, the editors of eBioMedicine no longer have confidence in the integrity of the data and retract both the paper and related Corrigendum. RETRACTED: Corrigendum to 'MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway' [EBioMedicine 46 (2019) 66–78]This article has been retracted: please see Elsevier Policy on Article Withdrawal ( https://www.elsevier.com/locate/withdrawalpolicy ). Full-Text PDF Open Access
Retraction Note: Decreased Expression of Mir-939 Contributes to Chemoresistance and Metastasis of Gastric Cancer Via Dysregulation of SLC34A2 and Raf/MEK/ERK Pathway

Jia-Xing Zhang,Yi Xu,Ying Gao,Cui Chen,Zhou-San Zheng,Miao Yun,Hui-Wen Weng,Dan Xie,Sheng Ye

DOI: https://doi.org/10.1186/s12943-022-01702-w

IF: 37.3

2022-01-01

Molecular Cancer

Abstract:This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s12943-017-0586-y.
[Retracted] miR‐660‐5p is associated with cell migration, invasion, proliferation and apoptosis in renal cell carcinoma

Tao He,Peijie Chen,Lu Jin,Jia Hu,Yifan Li,Liang Zhou,Shangqi Yang,Xiangming Mao,Yaoting Gui,Yun Chen,Yongqing Lai

DOI: https://doi.org/10.3892/mmr.2024.13210

IF: 3.423

2024-03-28

Molecular Medicine Reports

Abstract:Following the publication of the above article, the authors contacted the Editorial Office to explain that a couple of errors concerning data handling/labelling had been made, firstly during the preparation of the representative images in Fig. 3B, resulting in the wrong image being selected for the data panel showing the ACHN cells treated with 'Inhibitor NC' at 0 h experiment, and secondly in Fig. 5A, resulting in the wrong image being selected for the data panel showing the ACHN cells treated with 'Inhibitor NC' experiment. The authors requested that a corrigendum be published to take account of the errors that were made during the preparation of this figure. Subsequently, an independent investigation of the published data was undertaken by the Editorial Office, which revealed that the 'Inhibitor' data panel in Fig. 6A and the 'Mimic NC' data panel in Fig. 6B were also overlapping, such that these data were likely to have been derived from the same original source, even though these data panels were intended to have shown the results from differently performed experiments. The Editor of Molecular Medicine Reports has considered the authors' request to publish a corrigendum, but given the number of overlapping data panels that have been identified and the number of figures that would be in need of correction, the Editor has decided to decline the authors' request to publish a corrigendum on account of an overall lack of confidence in the presented data, and instead has determined that the paper should be retracted. Upon receiving this news from the Editor, the authors accepted the Editor's decision. The Editor apologizes to the readership of the Journal for any inconvenience caused. [Molecular Medicine Reports 17: 2051‐2060, 2018; DOI: 10.3892/mmr.2017.8052]

oncology,medicine, research & experimental
Retracted: A Regulatory Axis of Circ_0008193/mir-1180-3p/trim62 Suppresses Proliferation, Migration, Invasion, and Warburg Effect in Lung Adenocarcinoma Cells under Hypoxia

Minbiao Chen,Xinxin Huang,Liang Li,Mingfang Huang,Renzhong Cai,Xuqiang Liao

DOI: https://doi.org/10.12659/msm.940684

2023-01-01

Medical Science Monitor

Abstract:This publication has been retracted by the Editor due to non-original content and deficiencies in the conduct of the study. Reference: Minbiao Chen, Xiuming Huang, Liang Li, Mingfang Huang, Renzhong Cai, Xuqiang Liao.A Regulatory Axis of circ_0008193/miR-1180-3p/TRIM62 Suppresses Proliferation, Migration, Invasion, and Warburg Effect in Lung Adenocarcinoma Cells Under Hypoxia. Med Sci Monit, 2020; 26: e922900. DOI: 10.12659/MSM.922900.
[Retracted] MicroRNA‐320a suppresses tumour cell proliferation and invasion of renal cancer cells by targeting FoxM1

Shiyue Zhao,Yangwei Wang,Yan Lou,Yonggang Wang,Jing Sun,Manyu Luo,Wen Li,Lining Miao

DOI: https://doi.org/10.3892/or.2024.8754

2024-06-12

Oncology Reports

Abstract:Subsequently to the publication of the above paper, the authors drew to the attention of the Editorial Office that they made a couple of errors in terms of the data assembly in Figs. 2 and 4 in their paper; specifically, the Transwell assay data shown for the 'miR-320a+/FoxM1+' panel in Fig. 5D on p. 1923 also appeared as the 'ACTN/NC' data panel in Fig. 4E on the same page (Fig. 4E contained the erroneously duplicated panel). In addition, data featured in Fig. 2D of the above paper were strikingly similar to data that appeared in Fig. 6e of the following paper, published subsequently to this article, written by different authors (although a Dr Shiyue Zhao worked in the molecular biology laboratory of Harbin Medical University from 2017 to 2018, and the research collaboration was conducted with Dr Chenlong Li's research group): Li C, Zheng H, Hou W, Bao H, Xiong J, Che W, Gu Y, Sun H and Liang P: Long non-coding RNA linc00645 promotes. TGF-β-induced epithelial-mesenchymal transition by regulating miR-205-3p-ZEB1 axis in glioma. Cell Death Dis 10: 17, 2019. Finally, after having conducted an independent investigation of the data in this paper, the Editorial Office noted that one of the Petri dish images in Fig. 2C was also strikingly similar to data that appeared in Fig. 2H of the abovementioned article in the journal Cell Death & Disease . After having considered the authors' request for corrigendum, in view of the problems that were identified with the data, the Editor of Oncology Reports has decided that, owing to a lack of confidence in the presented data, the paper should instead be retracted from the journal. After having informed the authors of this decision, they accepted the decision to retract this paper. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 40: 1917‐1926, 2018; DOI: 10.3892/or.2018.6597]

oncology
[Retracted] miR‐148a‐3p suppresses epithelial ovarian cancer progression primarily by targeting c‐Met

Wen Wang,Jing Dong,Maoxiu Wang,Shujuan Yao,Xiangyu Tian,Xiujuan Cui,Shijie Fu,Shiqian Zhang

DOI: https://doi.org/10.3892/ol.2024.14644

2024-08-30

Oncology Letters

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the invasion assay data shown in Fig. 2C on p. 6134 had already appeared in an article written by different authors that had already been submitted for publication [Li P, Wang H, Hou M, Li D and Bai H: Upstream stimulating factor 1 (USF1) enhances the proliferation of glioblastoma stem cells mainly by activating the transcription of mucin 13 (MUC13). Pharmazie 72: 98-102, 2017]. Owing to the fact that the contentious data in the above article had already been submitted for publication prior to its submission to Oncology Letters , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Letters 15: 6131-6136, 2018; DOI: 10.3892/ol.2018.8110]

oncology
RETRACTED:Inhibition of KRAS Gene Mutation on Non-Small Cell Lung Cancer and Its Effect on Circulating Tumor Cells

Ji Yanli,Lu Wei,Che Guowei,Yang Mei,Liu Lunxu

DOI: https://doi.org/10.1016/j.future.2018.12.010

IF: 7.307

2019-01-01

Future Generation Computer Systems

Abstract:This article has been retracted: please see Elsevier Policy on Article Withdrawal ( https://www.elsevier.com/about/ourbusiness/policies/article-withdrawal ). This article has been retracted at the request of the Authors. The authors of this article have informed the journal and the Editors, that none of the authors listed had any involvement with or knowledge of the article. Using someone else’s name as an author represents a clear violation of the fundamentals of peer review, our publishing policies, and publishing ethics standards. Apologies are offered to readers of the article.
[Retracted] MicroRNA‐320 targets mitogen‐activated protein kinase 1 to inhibit cell proliferation and invasion in epithelial ovarian cancer

Yongqian Xu,Jian Hu,Chunxia Zhang,Yuanyuan Liu

DOI: https://doi.org/10.3892/mmr.2024.13169

IF: 3.423

2024-01-23

Molecular Medicine Reports

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the Transwell cell invasion assay data shown in Fig. 5C on p. 8534 were strikingly similar to data that had already been published in different form in different articles written by different authors at different research institutes, or were submitted for publication at around the same time (several of which have now been retracted). Owing to the fact that some of the data in the above article had already been published prior to its submission to Molecular Medicine Reports , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 16: 8530‐8536, 2017; DOI: 10.3892/mmr.2017.7664]

oncology,medicine, research & experimental
WITHDRAWN: Long Intergenic Non-Coding RNA LINC00662 Contributes to Malignant Growth of Colorectal Cancer Cells by Upregulating C-Myc Via Sponging Microrna-145

Zhifeng Yao,Danghui Xu,Zhanfeng Li,Jianxin Yao,Zhiyao Pan,Jinfei Chen

DOI: https://doi.org/10.1042/bsr20200011

2020-01-01

Bioscience Reports

Abstract:The Accepted Manuscript version of this article (published on 29 May 2020) was withdrawn on 29 July 2020 at the request of the authors due to concerns over data validity.
RETRACTED: MiR-650 Regulates the Proliferation, Migration and Invasion of Human Oral Cancer by Targeting Growth Factor Independent 1 (Gfi1).

Sun Ningning,Sun Libo,Wu Chuanbin,Sun Haijiang,Zhou Qing

DOI: https://doi.org/10.1016/j.biochi.2018.10.001

IF: 4.372

2018-01-01

Biochimie

Abstract:This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal).This article has been retracted at the request of the Editor-in-Chief.Following concerns raised by Dr. E. Bik and an anonymous reader, the journal conducted an investigation and found evidence that there had been improper manipulation and duplication of images in Figures 2A, 5C and 6C, as shown by partial overlap between images representing different experiments. An anonymous reader has also drawn attention to flow-cytometry data in Figure 1 similar to previously published data from a different laboratory (Med Sci Monit, 2018; 24: 5874-5880 DOI: 10.12659/MSM.909682, Figure 2B). After raising the complaint with the authors, the corresponding author agreed that the paper needed to be retracted.The authors apologise for any confusion that may have arisen from their article.
Withdrawn: Z. Cui, Q. Sun, W. Yan, Q. Han, G. Wang, Y. Hu. The role of miR-320a and its target gene GMEB1 in epithelial-mesenchymal transition and invasion of colorectal cancer, published in The Journal of Gene Medicine.

Zhi Cui,Qiong Sun,Wenji Yan,Quanli Han,Guanjun Wang,Yi Hu

DOI: https://doi.org/10.1002/jgm.3327

2023-01-01

The Journal of Gene Medicine

Abstract:The above article, published online on 22 February 2021 in Wiley Online Library (wileyonlinelibrary.com), has been withdrawn by agreement between the journal Editor in Chief, Gening Jiang, and John Wiley & Sons Ltd. The withdrawal has been agreed following no response from the author to requests to sign the Journal's publishing license.
WITHDRAWN: ESM1-dependent mesenchymal transition enhances radioresistance of glioblastoma via transcriptional regulation of NFκB.

Jia Wang,Jie Zuo,Alafate Wahafu,Hai Yu,Wanfu Xie,Hua Zhang,Maode Wang

DOI: https://doi.org/10.1016/j.bbrc.2019.10.126

IF: 3.1

2019-01-01

Biochemical and Biophysical Research Communications

Abstract:This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal.

WITHDRAWN: <i>MiR-760</i> inhibits the progression of non-small cell lung cancer through blocking <i> <i>ROS1</i> </i>/Ras/Raf/MEK/ERK pathway

MiR-30 Suppresses Lung Cancer Cell 95D Epithelial Mesenchymal Transition and Invasion Through Targeted Regulating Snail.

WITHDRAWN: Mir-504 Affects the Radio-Resistance in Nasopharyngeal Carcinoma by Down-Regulating the Expression of Nuclear Respiratory Factor 1

[Retracted] MicroRNA‑874 Inhibits Growth, Induces Apoptosis and Reverses Chemoresistance in Colorectal Cancer by Targeting X‑linked Inhibitor of Apoptosis Protein

[Retracted] miR‐17‐5p promotes the growth of osteosarcoma in a BRCC2‐dependent mechanism

[Retracted] MicroRNA‐520a attenuates proliferation of Raji cells through inhibition of AKT1/NF‐κB and PERK/eIF2α signaling pathway

Withdrawal: Down‐regulation of Circrna_0000143 Regulates Mir‐142‐3p/grα Axis to Facilitate the Progression of T‐ALL

[Retracted] MicroRNA‐219 is downregulated in non‐small cell lung cancer and inhibits cell growth and metastasis by targeting HMGA2

MicroRNA-664 Targets Paired Box Protein 6 to Inhibit the Oncogenicity of Pancreatic Ductal Adenocarcinoma.

Retraction Notice to “corrigendum to ‘Microrna-134 Prevents the Progression of Esophageal Squamous Cell Carcinoma Via the PLXNA1-mediated MAPK Signalling Pathway’ [ebiomedicine 46 (2019) 66–78]” [ebiomedicine 55 (2020) 102772]

Retraction Note: Decreased Expression of Mir-939 Contributes to Chemoresistance and Metastasis of Gastric Cancer Via Dysregulation of SLC34A2 and Raf/MEK/ERK Pathway

[Retracted] miR‐660‐5p is associated with cell migration, invasion, proliferation and apoptosis in renal cell carcinoma

Retracted: A Regulatory Axis of Circ_0008193/mir-1180-3p/trim62 Suppresses Proliferation, Migration, Invasion, and Warburg Effect in Lung Adenocarcinoma Cells under Hypoxia

[Retracted] MicroRNA‐320a suppresses tumour cell proliferation and invasion of renal cancer cells by targeting FoxM1

[Retracted] miR‐148a‐3p suppresses epithelial ovarian cancer progression primarily by targeting c‐Met

RETRACTED:Inhibition of KRAS Gene Mutation on Non-Small Cell Lung Cancer and Its Effect on Circulating Tumor Cells

[Retracted] MicroRNA‐320 targets mitogen‐activated protein kinase 1 to inhibit cell proliferation and invasion in epithelial ovarian cancer

WITHDRAWN: Long Intergenic Non-Coding RNA LINC00662 Contributes to Malignant Growth of Colorectal Cancer Cells by Upregulating C-Myc Via Sponging Microrna-145

RETRACTED: MiR-650 Regulates the Proliferation, Migration and Invasion of Human Oral Cancer by Targeting Growth Factor Independent 1 (Gfi1).

Withdrawn: Z. Cui, Q. Sun, W. Yan, Q. Han, G. Wang, Y. Hu. The role of miR-320a and its target gene GMEB1 in epithelial-mesenchymal transition and invasion of colorectal cancer, published in The Journal of Gene Medicine.

WITHDRAWN: ESM1-dependent mesenchymal transition enhances radioresistance of glioblastoma via transcriptional regulation of NFκB.